Chidozie Ugwumba

Chidozie Ugwumba is a prominent financial and investment professional currently serving as the Managing Partner at SymBiosis Capital Management since 2021. Ugwumba has held various board positions, including Board Member at Carisma Therapeutics from 2021 to 2024, Micronoma from 2020 to 2024, Clene Nanomedicine from 2021 to 2023, and PlateletBio from 2021 to 2022, as well as Board Observer roles at Biosplice Therapeutics and Enterome. Prior experience includes serving as Managing Director of Direct Investments at WIT, LLC, from 2018 to 2021, and as Assistant Vice President and Americas Head at Partners Group from 2015 to 2018. Ugwumba holds an M.B.A. from the Cornell Johnson Graduate School of Management and a B.A. in Political Science from Amherst College.